Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Eklund

Showing results (61-70 of 207) with videos related to

Pageof 21
Sort By:
European Urology Oncology|June 26, 2019
Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate CancerHenrik Olsson, Tobias Nordström, Mark Clements, et al.
European Urology Focus|December 15, 2022
External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening CohortThorgerdur Palsdottir, Henrik Grönberg, Arnaldur Hilmisson, et al.
European Urology Open Science|April 20, 2026
Trends and Patterns in Prostate Cancer Diagnostics During the Era of MRI Implementation - Real-world Evidence From a Population-based Study in the Stockholm Region, Sweden 2010-2023Jan Chandra Engel, Balram Rai, Martin Eklund, et al.
Plos One|February 15, 2019
A natural history model for planning prostate cancer testing: Calibration and validation using Swedish registry dataAndreas Karlsson, Alexandra Jauhiainen, Roman Gulati, et al.
Bioinformatics (Oxford, England)|August 6, 2021
OpenPhi: an interface to access Philips iSyntax whole slide images for computational pathologyNita Mulliqi, Kimmo Kartasalo, Henrik Olsson, et al.
European Urology Oncology|August 15, 2019
A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance ImagingThorgerdur Palsdottir, Tobias Nordström, Markus Aly, et al.
Pathology|February 9, 2025
Gleason scores provide more accurate prognostic information than grade groupsLars Egevad, Chiara Micoli, Brett Delahunt, et al.
World Journal of Urology|August 1, 2020
Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancerLars Björnebo, Henrik Olsson, Tobias Nordström, et al.
Medical Image Analysis|July 11, 2025
Hierarchical Vision Transformers for prostate biopsy grading: Towards bridging the generalization gapClément Grisi, Kimmo Kartasalo, Martin Eklund, et al.
BMC Health Services Research|May 22, 2020
The economic burden of prostate cancer - a Swedish prevalence-based register studyShuang Hao, Ellinor Östensson, Martin Eklund, et al.
Pageof 21

Showing results (61-70 of 207) with videos related to

Sort By:
Pageof 21
European Urology Oncology|June 26, 2019
Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate CancerHenrik Olsson, Tobias Nordström, Mark Clements, et al.
European Urology Focus|December 15, 2022
External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening CohortThorgerdur Palsdottir, Henrik Grönberg, Arnaldur Hilmisson, et al.
European Urology Open Science|April 20, 2026
Trends and Patterns in Prostate Cancer Diagnostics During the Era of MRI Implementation - Real-world Evidence From a Population-based Study in the Stockholm Region, Sweden 2010-2023Jan Chandra Engel, Balram Rai, Martin Eklund, et al.
Plos One|February 15, 2019
A natural history model for planning prostate cancer testing: Calibration and validation using Swedish registry dataAndreas Karlsson, Alexandra Jauhiainen, Roman Gulati, et al.
Bioinformatics (Oxford, England)|August 6, 2021
OpenPhi: an interface to access Philips iSyntax whole slide images for computational pathologyNita Mulliqi, Kimmo Kartasalo, Henrik Olsson, et al.
European Urology Oncology|August 15, 2019
A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance ImagingThorgerdur Palsdottir, Tobias Nordström, Markus Aly, et al.
Pathology|February 9, 2025
Gleason scores provide more accurate prognostic information than grade groupsLars Egevad, Chiara Micoli, Brett Delahunt, et al.
World Journal of Urology|August 1, 2020
Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancerLars Björnebo, Henrik Olsson, Tobias Nordström, et al.
Medical Image Analysis|July 11, 2025
Hierarchical Vision Transformers for prostate biopsy grading: Towards bridging the generalization gapClément Grisi, Kimmo Kartasalo, Martin Eklund, et al.
BMC Health Services Research|May 22, 2020
The economic burden of prostate cancer - a Swedish prevalence-based register studyShuang Hao, Ellinor Östensson, Martin Eklund, et al.
Pageof 21